Medical Marijuana Products and Methods of Use

Walking into a cannabis dispensary can feel very different from picking up a conventional prescription.

Medical marijuana may be available as dried flower, pre-rolls, vaporized products, concentrates, gummies, other edibles, capsules, oils, tinctures, topical preparations, and products containing widely different amounts of tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids.

These products are not interchangeable.

The method by which cannabis enters the body can substantially affect how quickly its effects begin, how long they last, how predictable the response may be, and which risks deserve the most attention.

A person using a small amount of an inhaled product may experience effects within minutes, while someone swallowing an edible may not experience its full effects until much later. The same amount of THC may also feel different when inhaled compared with when it is swallowed.

For patients considering medical marijuana, understanding these differences is an important part of responsible use.

If you are new to this subject, it may be helpful to first read How Medical Cannabis Affects the Body, which explains THC, CBD, the endocannabinoid system, and why cannabis affects different people differently.

Medical Marijuana Is Not One Standardized Product

The phrase medical marijuana can create the impression that cannabis is a single medication.

It is not.

Different products may contain dramatically different concentrations and combinations of cannabinoids. They may also enter the body through different routes.

Important variables include:

• THC concentration

• CBD concentration

• THC-to-CBD ratio

• Amount consumed

• Route of administration

• Product formulation

• Frequency of use

• Previous cannabis exposure and tolerance

• Individual metabolism

• Other medications and substances being used

• The symptom or condition being addressed

This helps explain why two products sold for medical use may produce very different experiences.

It also explains why a strain name alone is usually not enough information to predict what a product will do.

For most patients, clinically useful information includes the actual cannabinoid content, amount being used, route of administration, previous response, and adverse effects rather than relying exclusively on labels such as indica, sativa, or a particular strain name.

Arizona's current medical marijuana rules require dispensary labeling to include information such as the product's form, batch information, and laboratory-based potency, including total THC and total CBD. Marijuana products must also undergo required laboratory testing before being offered for dispensing.

Why the Method of Use Matters

The route of administration determines how cannabinoids enter the bloodstream and how they are processed by the body.

That can change several clinically important characteristics:

Onset: How quickly effects begin.

Peak effect: When the effects are strongest.

Duration: How long noticeable effects may persist.

Dose predictability: How easily someone can estimate the amount they are receiving.

Metabolism: Whether cannabinoids are absorbed primarily through the lungs, gastrointestinal tract, oral tissues, skin, or another pathway.

Safety considerations: Whether the method involves combustion, pulmonary exposure, delayed dosing, highly concentrated THC, or other risks.

There is therefore no universally "best" method of using medical marijuana.

The most appropriate option—when cannabis is medically appropriate at all—depends on the individual patient and treatment goal.

Cannabis Flower

Cannabis flower refers to the dried portion of the cannabis plant that is commonly smoked or vaporized.

Products can vary considerably in THC and CBD concentration.

Why Some Patients Choose Inhaled Flower

The main practical characteristic of inhaled cannabis is its relatively rapid onset.

Cannabinoids absorbed through the lungs can enter the bloodstream quickly, and THC concentrations rise rapidly following inhalation. This allows patients to notice effects much sooner than they typically would with an oral product.

From a clinical standpoint, rapid onset can make the relationship between exposure and effect easier to recognize.

However, rapid onset does not make inhaled cannabis safer or more medically appropriate for everyone.

The Problem With Smoking Cannabis

Smoking requires combustion.

That exposes the respiratory tract not only to cannabinoids but also to smoke and combustion products.

The Centers for Disease Control and Prevention notes that smoked cannabis can damage lung tissue and contains many of the same toxins and irritants found in tobacco smoke.

Patients with asthma, chronic bronchitis, chronic obstructive pulmonary disease, or other respiratory conditions may have additional reasons to avoid inhaled smoke.

Someone should therefore not assume that using cannabis for a medical purpose eliminates the pulmonary consequences of smoking it.

Vaporized Cannabis

Cannabis can also be inhaled through vaporization.

This category includes vaporized flower as well as oils and concentrated products used in vaping devices.

Like smoking, vaporized cannabis generally produces a relatively rapid onset because cannabinoids are absorbed through the lungs.

One potential distinction is that vaporization does not necessarily involve burning plant material in the same way that smoking does.

That does not mean vaping cannabis is harmless.

The health effects depend on the device, temperature, formulation, cannabinoid concentration, additives, contaminants, and source of the product. Public-health data have also identified potential lung injury concerns associated with contaminants in some cannabis vaping products.

Patients who use inhaled products should obtain them through legal, regulated sources rather than assuming that an unknown cartridge or concentrate contains what its packaging claims.

Cannabis Concentrates

Cannabis extracts and concentrates include products sometimes described as oils, waxes, shatter, resin, rosin, or other concentrated preparations.

The terminology can be confusing because a concentrate is a type of product rather than one single method of administration.

Depending on the formulation, concentrates may be vaporized, incorporated into another product, or used in other ways.

The major clinical issue is often potency.

Some concentrates can contain substantially higher concentrations of THC than cannabis flower.

Higher potency can make it easier for a patient to receive a much larger THC exposure than intended.

Higher THC exposure can increase the likelihood of:

• Cognitive impairment

• Dizziness

• Anxiety

• Panic

• Paranoia

• Poor coordination

• Sedation

• Rapid heart rate

• Uncomfortable intoxication

CDC surveillance literature specifically identifies highly concentrated THC products, including products used for dabbing, as a potential source of increased acute health risks.

For someone who is inexperienced with cannabis or particularly sensitive to THC, a very high-potency concentrate may therefore be difficult to use predictably.

Edible Medical Marijuana Products

Edibles are cannabis-containing foods or beverages.

Examples can include gummies, chocolates, baked products, lozenges, beverages, and other infused foods.

Arizona regulates marijuana-infused edible products and requires dispensaries involved in preparing or dispensing them to comply with applicable food-establishment requirements.

Edibles are popular partly because they avoid inhaling smoke or vapor.

However, they introduce an entirely different challenge:

Their effects are delayed.

The CDC notes that edible cannabis may take approximately 30 minutes to 2 hours to produce intoxicating effects. Effects may also last longer than expected depending on the amount consumed, other substances or medications, whether food was eaten, and individual factors.

Why Edibles Can Feel Stronger or Different

When THC is swallowed, it passes through the gastrointestinal tract and is processed by the liver.

During this process, THC is converted partly into metabolites including 11-hydroxy-THC, which is also psychoactive.

Oral cannabis therefore has different pharmacokinetics from inhaled cannabis.

The delayed onset is one of the most important practical considerations.

A common problem occurs when someone takes an edible, feels little effect initially, assumes the amount was insufficient, and takes more.

The original dose may then begin working at approximately the same time as the additional dose.

The result can be much more THC exposure than intended.

This is why patience is particularly important with oral cannabis.

Cannabis Capsules and Softgels

Capsules and softgels contain measured amounts of cannabis extract or individual cannabinoids.

They share many characteristics with other swallowed cannabis products.

Because the contents are swallowed, their effects are generally delayed compared with inhaled cannabis.

One potential advantage is dose consistency.

A labeled capsule containing a specified amount of THC or CBD may make it easier to keep track of exposure than estimating an amount from loose cannabis flower.

However, a precisely measured dose is not necessarily the same thing as a predictable clinical response.

Two people taking the same labeled amount can still experience different effects because of differences in:

• Gastrointestinal absorption

• Liver metabolism

• Food intake

• Age

• Previous cannabis exposure

• Other medications

• Body composition

• Individual sensitivity to cannabinoids

Oral products should therefore still be approached cautiously.

Cannabis Tinctures and Oils

The terms tincture and oil are often used broadly for liquid cannabis preparations.

These products may contain THC, CBD, or a combination of cannabinoids suspended or dissolved in a carrier.

How the product is actually used matters.

A liquid may be:

• Held in the mouth or beneath the tongue

• Swallowed

• Mixed into food or beverages

If most of the product is swallowed, its pharmacology becomes more similar to other oral cannabis products.

Products intended for absorption through tissues inside the mouth may have a somewhat different onset because some cannabinoids may be absorbed before reaching the gastrointestinal tract.

However, real-world absorption can vary considerably depending on the formulation and how the product is used.

Patients should therefore avoid assuming that every product labeled "tincture" behaves identically.

Sublingual and Oromucosal Cannabis

Sublingual means under the tongue, while oromucosal refers more broadly to absorption through tissues of the mouth.

Some cannabis oils, sprays, or tinctures are intended for this type of administration.

In theory, absorption through oral tissues can partially bypass the gastrointestinal tract and first-pass liver metabolism.

In practice, some portion of a liquid product is usually swallowed, meaning that the resulting effects may reflect a combination of mucosal and gastrointestinal absorption.

This is another example of why the product label and formulation matter.

The method of administration cannot always be determined simply by looking at the bottle.

Topical Cannabis Products

Topical products are applied to the skin.

They may include:

• Creams

• Lotions

• Balms

• Salves

• Gels

• Oils

Many are marketed for localized discomfort involving muscles, joints, or other tissues.

Most ordinary topical cannabis products are intended primarily for local application and are not designed to produce the same systemic THC exposure associated with smoking or swallowing cannabis.

However, the evidence supporting many topical cannabis claims remains limited.

Patients should also distinguish ordinary topical products from transdermal formulations, which are specifically designed to move compounds across the skin and into systemic circulation.

Formulation matters.

The fact that something is applied to the skin does not automatically tell you how much of a cannabinoid reaches deeper tissue or the bloodstream.

What Is the Difference Between THC-Dominant and CBD-Dominant Products?

Route of administration is only half of the discussion.

Cannabinoid composition matters just as much.

THC-Dominant Products

THC is primarily responsible for the characteristic intoxicating effects of cannabis.

Depending on the individual and dose, THC may influence:

• Pain perception

• Appetite

• Nausea

• Mood

• Relaxation

• Sleepiness

• Sensory perception

But THC can also impair:

• Attention

• Memory

• Reaction time

• Coordination

• Judgment

• Decision-making

Higher THC exposure generally increases concern about impairment and adverse psychological effects.

CBD-Dominant Products

CBD does not produce the same characteristic intoxication as THC.

That does not mean CBD is inactive or risk-free.

CBD can cause drowsiness, gastrointestinal symptoms, appetite changes, and other effects. It can also affect enzymes involved in the metabolism of certain medications.

The FDA specifically warns that CBD can interact with other medications and that clinically meaningful safety questions remain regarding liver effects and long-term use.

Patients should therefore include CBD when telling their physician which medications, supplements, and cannabis products they use.

What About Products Containing Both THC and CBD?

Many cannabis products contain both cannabinoids.

The ratio can vary widely.

Examples might be described as THC-dominant, CBD-dominant, or balanced depending on their composition.

CBD does not simply "cancel out" THC.

The interaction between cannabinoids is more complicated, and patients should not assume that adding CBD makes a high-THC product incapable of causing impairment.

The amount of THC someone actually receives remains an important consideration.

Is a Certain Strain Better for a Specific Medical Condition?

Patients frequently encounter recommendations based on terms such as:

Indica

Sativa

Hybrid

or specific strain names.

These descriptions may have practical or commercial meaning, but they should not be treated as precise medical dosing systems.

The effects of a cannabis product depend on far more than its strain name.

Cannabinoid concentration, THC-to-CBD ratio, amount used, route of administration, previous exposure, metabolism, and individual biology often provide more clinically useful information.

Terpenes and minor cannabinoids are scientifically interesting and remain active areas of research, but current evidence does not allow physicians to reliably predict that a particular terpene profile or strain will produce one specific therapeutic effect in every patient.

The National Institutes of Health continues to fund research examining cannabinoids, minor cannabinoids, terpenes, pain, sleep, mental health, and other potential therapeutic applications.

How Should Patients Read a Cannabis Product Label?

A patient does not need to become a cannabis chemist, but understanding several pieces of information can be helpful.

Look for the amount or concentration of:

Total THC

THC is particularly relevant to intoxication, cognitive impairment, coordination, anxiety, and other dose-related effects.

Total CBD

CBD does not cause the same characteristic intoxication but may still produce effects and medication interactions.

Amount per serving or unit

For gummies, capsules, or similar products, the amount per individual unit may be more useful than simply knowing how much cannabinoid is present in the entire package.

Total amount in the package

This is not necessarily the amount intended for one use.

Product form

Whether the product is inhaled, swallowed, used in the mouth, or applied topically changes its pharmacology.

Arizona's medical marijuana rules require dispensary products to include laboratory-based cannabinoid potency information and other identifying information on the label.

Are Dispensary Cannabis Products FDA Approved?

Generally, no.

The cannabis products sold through state marijuana programs should not be confused with FDA-approved medications.

The FDA has not approved the cannabis plant itself as a treatment for a disease or medical condition.

There are, however, specific FDA-approved cannabinoid medications, including a purified cannabidiol medication and synthetic cannabinoid-related medications for certain approved indications.

This distinction is important.

Evidence involving a standardized pharmaceutical cannabinoid cannot automatically be applied to every flower, edible, tincture, concentrate, or topical product sold through a dispensary.

Which Method of Medical Marijuana Use Is Best?

There is no single answer.

A useful way to think about product selection is to ask what characteristics matter for the individual patient.

How Quickly Is an Effect Needed?

Inhaled products generally produce effects faster than swallowed products.

That may matter when symptoms are intermittent or rapidly changing.

How Long Does the Effect Need to Last?

Oral products tend to have a slower onset but may produce effects that persist longer.

That can be useful in some situations and problematic in others.

Does the Patient Have Lung Disease?

Smoking may be particularly undesirable for someone with pulmonary disease.

Even vaporized products are not risk-free.

Does the Patient Need to Avoid Intoxication?

A person who drives professionally, operates machinery, cares for children, has significant fall risk, or performs safety-sensitive work may have a particularly low tolerance for cognitive impairment.

Is Dose Predictability Important?

Products divided into clearly labeled units may make cannabinoid exposure easier to track than products in which the amount consumed is difficult to estimate.

Does the Patient Have a History of Anxiety or Psychiatric Symptoms?

High THC exposure can worsen anxiety, panic, paranoia, or other psychiatric symptoms in some individuals.

What Other Medications Are Being Used?

Cannabis should be reviewed alongside prescription medications, over-the-counter medications, supplements, and alcohol.

What Has the Patient Used Before?

Someone with no previous cannabis exposure may respond very differently from someone who has developed substantial tolerance through frequent use.

Why "Start Low and Go Slow" Is Commonly Discussed

Cannabis has substantial person-to-person variability.

Using a large amount initially makes it difficult to determine whether a smaller amount might have provided the desired effect with fewer adverse effects.

This issue is especially important with THC.

More THC does not necessarily mean greater therapeutic benefit.

At some point, increasing exposure may predominantly increase:

• Sedation

• Dizziness

• Cognitive impairment

• Anxiety

• Poor coordination

• Cardiovascular effects

• Other unwanted symptoms

With oral products, increasing exposure too rapidly is particularly problematic because the full effect may not be apparent immediately.

The goal of medical use should be the lowest exposure that provides meaningful benefit with acceptable adverse effects, not simply the strongest product available.

Medical Marijuana and Driving

No method of administration makes it appropriate to drive while impaired.

Cannabis can impair reaction time, coordination, perception, attention, and decision-making.

The CDC specifically advises against driving after cannabis use because these effects interfere with abilities required for safe driving.

A medical marijuana card does not make impairment medically harmless.

Patients also should not assume that the effects have completely resolved simply because the strongest subjective sensation has passed.

Cannabis, Alcohol, and Sedating Medications

Using cannabis with other substances can change its effects.

Alcohol can increase impairment when combined with cannabis.

Additional caution may also be appropriate with medications that cause:

• Sedation

• Dizziness

• Cognitive slowing

• Reduced coordination

• Blood-pressure changes

Medication interactions are particularly important in patients using multiple prescriptions.

CBD can also alter the metabolism of certain medications.

A complete medication review should therefore include both THC- and CBD-containing products.

Medical Marijuana During Pregnancy and Breastfeeding

Changing from smoking to an edible, tincture, or topical product does not make cannabis automatically safe during pregnancy.

The FDA advises against the use of marijuana, THC, and CBD during pregnancy and breastfeeding.

Patients who are pregnant, attempting pregnancy, or breastfeeding should discuss cannabis use with their healthcare professional.

Safe Storage Matters With Every Product

Edibles deserve particular attention because they may resemble ordinary food or candy.

Children—and sometimes adults—may consume them without realizing they contain THC.

The CDC warns that edible cannabis products can cause unintentional poisoning, particularly because of their delayed effects and the possibility of consuming more than intended.

Cannabis products should be:

• Kept away from children and pets

• Stored separately from ordinary food when practical

• Kept in clearly identifiable packaging

• Secured so they cannot be accessed unintentionally

This is especially important for gummies, chocolates, baked products, and beverages.

Medical Marijuana Product Choice Should Be Individualized

Product selection should not begin with the question:

"What is the strongest product?"

A more useful set of questions is:

What symptom is being treated?

When does the symptom occur?

How quickly is an effect needed?

How long should the effect last?

How much impairment would be unacceptable?

Does the patient have pulmonary, cardiovascular, neurological, or psychiatric risk factors?

What medications are already being used?

Has cannabis been used previously?

Did it actually improve function or quality of life?

Were there side effects?

These questions place medical marijuana in its proper context: as one potential component of an individualized treatment plan rather than a product-shopping decision.

Patients interested in the physiology behind these differences can read How Medical Cannabis Affects the Body.

You can also review Medical Marijuana vs. Recreational Cannabis: What's the Difference? to understand how medical and adult-use cannabis differ in Arizona.

Who May Qualify for Medical Marijuana in Arizona?

The type of cannabis product a person prefers does not determine whether that individual qualifies for Arizona's medical marijuana program.

Eligibility is based on Arizona's qualifying medical conditions and the required medical evaluation.

Arizona recognizes specific diagnoses as well as certain chronic or debilitating conditions that produce qualifying symptoms.

You can review the current list in Qualifying Medical Conditions for Arizona Medical Marijuana Certification.

Patients who are new to the program can also read What Is Arizona Medical Marijuana? or explore the complete Medical Marijuana Resource Center.

The Bottom Line

Medical marijuana is available in many different formulations, and the product and method of administration can substantially change the patient's experience.

Inhaled cannabis generally has a rapid onset but exposes the respiratory system to smoke or vapor depending on the method.

Edibles and other swallowed products have a delayed onset and may last longer, which makes premature redosing an important safety concern.

Capsules and softgels may provide more clearly measured cannabinoid amounts but still have the variability associated with oral absorption.

Tinctures and oromucosal products may be absorbed partly through tissues in the mouth and partly through the gastrointestinal tract depending on the formulation and how they are used.

Topical products are generally intended for local application, while transdermal formulations may behave differently.

Concentrates can contain very high THC concentrations and may produce much greater cannabinoid exposure than inexperienced users expect.

No method is universally best.

The appropriate approach depends on the patient's medical condition, symptoms, treatment goals, previous cannabis exposure, medications, health history, occupational responsibilities, potential risks, and response to treatment.

For Arizona patients considering certification, a physician-guided medical marijuana evaluation can help determine whether the patient meets state requirements and whether medical marijuana is medically appropriate within the context of the patient's overall health.

Certification is based on an individualized medical evaluation and is not guaranteed.

How This Article Was Developed

This article was written and medically reviewed by YiQiu Hu, NMD, an Arizona-licensed naturopathic physician.

Because medical marijuana information involves both medical and regulatory considerations, this article was developed using authoritative state and federal sources.

Arizona-specific information was reviewed against the Arizona Department of Health Services Medical Marijuana Program and current ADHS medical marijuana regulations, including requirements governing product labeling, cannabinoid potency reporting, laboratory testing, and marijuana-infused edible products. Current Arizona rules require medical marijuana products dispensed to qualifying patients to include laboratory-based potency information and require applicable batches to undergo testing before being offered for dispensing.

Medical and safety information was reviewed using resources from the Centers for Disease Control and Prevention, National Institute on Drug Abuse, National Center for Complementary and Integrative Health, and U.S. Food and Drug Administration. These agencies emphasize that cannabis products can differ substantially in cannabinoid concentration, route of administration, onset, duration, impairment, adverse effects, and potential drug interactions.

Ask Dr. Hu's medical marijuana resources are periodically reviewed for changes in clinical evidence, safety guidance, and Arizona regulatory requirements.

Medical disclaimer: This article is intended for general educational purposes and does not replace individualized medical advice, diagnosis, or treatment. Medical marijuana is not appropriate for every patient. Do not drive, operate machinery, or perform safety-sensitive activities while impaired by cannabis.

About the Author

YiQiu Hu, NMD is an Arizona-licensed naturopathic physician and founder of Ask Dr. Hu. He provides concierge medicine, preventive healthcare, health optimization, medical marijuana evaluations, integrative pain management, laboratory testing, and individualized medical care for patients throughout Arizona.

Dr. Hu earned his Doctor of Naturopathic Medicine degree from Sonoran University of Health Sciences and a Bachelor of Science in Biomedical Sciences from Northern Arizona University. His clinical approach emphasizes thorough medical evaluation, evidence-informed care, clear patient education, and individualized treatment planning rather than one-size-fits-all recommendations.

Published August 2026 | Medically reviewed August 2026